Holding(s) in Company

Darktrace PLC

02 August 2024

 

TR-1: Standard form for notification of major holdings

1. Issuer Details

ISIN

GB00BNYK8G86

Issuer Name

DARKTRACE PLC

UK or Non-UK Issuer

UK

2. Reason for Notification

An acquisition or disposal of voting rights

3. Details of person subject to the notification obligation

Name

JPMorgan Chase & Co.

City of registered office (if applicable)

Country of registered office (if applicable)

US

4. Details of the shareholder

Name	City of registered office	Country of registered office
J.P. Morgan Securities plc

5. Date on which the threshold was crossed or reached

31-Jul-2024

6. Date on which Issuer notified

02-Aug-2024

7. Total positions of person(s) subject to the notification obligation

	% of voting rights attached to shares (total of 8.A)	% of voting rights through financial instruments (total of 8.B 1 + 8.B 2)	Total of both in % (8.A + 8.B)	Total number of voting rights held in issuer
Resulting situation on the date on which threshold was crossed or reached	4.053004	2.316943	6.369947	44617475
Position of previous notification (if applicable)	3.920081	2.319129	6.239210

8. Notified details of the resulting situation on the date on which the threshold was crossed or reached

8A. Voting rights attached to shares

Class/Type of shares ISIN code(if possible)	Number of direct voting rights (DTR5.1)	Number of indirect voting rights (DTR5.2.1)	% of direct voting rights (DTR5.1)	% of indirect voting rights (DTR5.2.1)
GB00BNYK8G86		28388766		4.053004
Sub Total 8.A	28388766		4.053004%

8B1. Financial Instruments according to (DTR5.3.1R.(1) (a))

Type of financial instrument	Expiration date	Exercise/conversion period	Number of voting rights that may be acquired if the instrument is exercised/converted	% of voting rights
Sub Total 8.B1

8B2. Financial Instruments with similar economic effect according to (DTR5.3.1R.(1) (b))

Type of financial instrument	Expiration date	Exercise/conversion period	Physical or cash settlement	Number of voting rights	% of voting rights
Cash-settled Equity Swap	12/11/2024	12/11/2024	Cash	5762562	0.822712
Cash-settled Equity Swap	10/02/2025	10/02/2025	Cash	1983	0.000283
Cash-settled Equity Swap	18/03/2025	18/03/2025	Cash	2675046	0.381912
Cash-settled Equity Swap	19/03/2025	19/03/2025	Cash	172785	0.024667
Cash-settled Equity Swap	31/07/2025	31/07/2025	Cash	15660	0.002235
Cash-settled Equity Swap	04/08/2025	04/08/2025	Cash	134305	0.019173
Cash-settled Equity Swap	13/08/2025	13/08/2025	Cash	7458450	1.064832
Cash-settled Equity Swap	30/05/2028	30/05/2028	Cash	7918	0.001129
Sub Total 8.B2				16228709	2.316943%

9. Information in relation to the person subject to the notification obligation

2. Full chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held starting with the ultimate controlling natural person or legal entities (please add additional rows as necessary)

Ultimate controlling person	Name of controlled undertaking	% of voting rights if it equals or is higher than the notifiable threshold	% of voting rights through financial instruments if it equals or is higher than the notifiable threshold	Total of both if it equals or is higher than the notifiable threshold
JPMorgan Chase & Co.	J.P. Morgan Securities plc	4.030702		6.347645%
JPMorgan Chase & Co.	J.P. Morgan Securities LLC
JPMorgan Chase & Co.	J.P. Morgan SE

10. In case of proxy voting

Name of the proxy holder

The number and % of voting rights held

The date until which the voting rights will be held

11. Additional Information

Chain of controlled undertakings:

JPMorgan Chase & Co.
JPMorgan Chase Bank, National Association (100%)
J.P. Morgan International Finance Limited (100%)
J.P. Morgan Capital Holdings Limited (100%)
J.P. Morgan Securities plc (100%)

JPMorgan Chase & Co.
JPMorgan Chase Holdings LLC (100%)
J.P. Morgan Broker-Dealer Holdings Inc. (100%)
J.P. Morgan Securities LLC (100%)

JPMorgan Chase & Co.
JPMorgan Chase Bank, National Association (100%)
J.P. Morgan International Finance Limited (100%)
J.P. Morgan SE (100%)

12. Date of Completion

02-Aug-2024

13. Place Of Completion

London, United Kingdom

 

END